Nimesulide does not affect active intrauterine pressure, as measured using microsensors, or the direction and velocity of the propagation of uterine activity, but nevertheless alleviates pain significantly by 30 minutes after oral administration. In dysmenorrhoeic patients, resting pressure is high only in the fundus. Nimesulide reduces the pressure during the maximal but not during the submaximal pain period, with concomitant alleviation of pain. The drug changes the painful state of uterine contracture to painless cyclic contractions. With a single oral dose of 100mg, nimesulide is evenly distributed in female genital tissues (uterine fundus and cervix, oviduct and ovaries), reaching peak concentrations and peak plasma: tissue ratio (0.5) 3 hours after administration. Tissue concentrations range from 0.3 to 1.8.μg/g. Two 100mg oral doses of nimesulide administered to dysmenorrhoeic women in a double-blind placebo-controlled cross-over study reduced prostaglandin F2α levels in menstrual blood from 382 to 94 μg/L. Double-blind placebo-controlled studies also confirmed that nimesulide relieves pain in dysmenorrhoeic patients.
KeywordsNaproxen Nimesulide Mefenamic Acid Diflunisal Menstrual Blood
Unable to display preview. Download preview PDF.
- Ekstrom P. Uterine activity and hyperactivity. Studies on the hormonal effects in the regulation of myometrial contractility and uterine blood flow of non-pregnant women with special regard to the mechanisms of dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica 71: 564–565, 1992CrossRefGoogle Scholar
- Moggian G, Pellgri E, Tamburini E, Pini P, Tumidei U. A new treatment for primary dysmenorrhea. Clinica Therapeutica 117: 481–492, 1986Google Scholar
- Morrison JC, Nicolls ET. Epidemiological, social, and economical aspects of dysmenorrhea. In Dawood MY (Ed.) Dysmenorrhea, pp. 95–106, Williams & Wilkins, Baltimore, 1981Google Scholar
- Pulkkinen MO. Diflunisal treatment before and during the dysmenorrheic period. In Diflunisal: profile of a modern analgesic, pp. 57–54, Waverly Press, Baltimore, 1982Google Scholar
- Pulkkinen MO. Analysis of uterine contractility. In Garfield RE (Ed.) Uterine contractility, pp. 295–308, Serono Symposia, Norwell, 1990Google Scholar
- Rondel RK, Eberhardt R, Koch J, Schuerman W. Treatment of primary essential dysmenorrhea with nimesulide in a double-blind cross-over study. Current Therapeutic Research 35: 123–129, 1984Google Scholar
- Ruponen S, Haataja M, Anttila M. Naproxen treatment in dysmenorrhea. Laakeuutiset 2: 43–45, 1978Google Scholar